{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:59Z","timestamp":1772166179298,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Due to the high variability of incidence and prevalence of intra-mammary lymph nodes (IMLNs), they might be overlooked during clinical and radiological examinations. Properly characterizing pathological IMLNs and detecting the factors that might influence their prevalence in different stages of breast cancer might aid in proper therapeutic decision-making and could be of possible prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records were reviewed for all breast cancer patients treated at the National Cancer Institute of Cairo University between 2013 and 2019. Radiological, pathological, and surgical data were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intra-mammary lymph nodes were described in the final pathology reports of 100 patients. Five cases had benign breast lesion. Three cases had phyllodes tumors and two cases had ductal carcinoma in situ (DCIS). All ten cases were excluded. The remaining 90 cases all had invasive breast cancer and were divided into two groups: one group for patients with malignant IMLNs (48) and another for patients with benign IMLNs (42). Pathological features of the malignant IMLN group included larger mean tumor size in pathology (4.7\u2009cm), larger mean size of the IMLN in pathology (1.7\u2009cm), higher incidence of lympho-vascular invasion (65.9%), and higher rate of extracapsular extension in axillary lymph nodes (57.4%). In addition, the pathological N stage was significantly higher in the malignant IMLN group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinicians frequently overlook intra-mammary lymph nodes. More effort should be performed to detect them during preoperative imaging and during pathological processing of specimens. A suspicious IMLN should undergo a percutaneous biopsy. Malignant IMLNs are associated with advanced pathological features and should be removed during surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-021-02219-0","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:28:28Z","timestamp":1618302508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intra-mammary lymph nodes, an overlooked breast cancer prognostic tool?"],"prefix":"10.1186","volume":"19","author":[{"given":"Tarek","family":"Hashem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdelmoez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Mohamed","family":"Rozeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"10","key":"2219_CR1","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/1097-0142(19830515)51:10<1838::AID-CNCR2820511014>3.0.CO;2-8","volume":"51","author":"RL Eagan","year":"1983","unstructured":"Eagan RL, McSweeney MB. Intramammary lymph nodes. Cancer. 1983;51(10):1838\u201342. https:\/\/doi.org\/10.1002\/1097-0142(19830515)51:10<1838::AID-CNCR2820511014>3.0.CO;2-8.","journal-title":"Cancer"},{"issue":"6","key":"2219_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.20515","volume":"101","author":"J Shen","year":"2004","unstructured":"Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer. 2004;101(6):1330\u20137. https:\/\/doi.org\/10.1002\/cncr.20515.","journal-title":"Cancer"},{"key":"2219_CR3","doi-asserted-by":"crossref","unstructured":"Sidiropoulou, Z., Ad\u00e9lia, F., Gil, I., Teles, T., Santos, C. and Monteiro, L., 2017. Case report: Intramammary lymph node metastasis of an unknown primary, probably occult breast, undifferentiated carcinoma. F1000Research, 6.","DOI":"10.12688\/f1000research.11065.1"},{"key":"2219_CR4","unstructured":"AJCC (American Joint Committee on Cancer) Cancer staging manual, seventh edition (2010) published by Springer International Publishing."},{"issue":"6","key":"2219_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00268-001-0006-7","volume":"25","author":"RF Uren","year":"2001","unstructured":"Uren RF, Howman-Giles R, Renwick SB, Gillett D. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg. 2001;25(6):789\u201393. https:\/\/doi.org\/10.1007\/s00268-001-0006-7.","journal-title":"World J Surg"},{"issue":"5","key":"2219_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1245\/s10434-007-9769-x","volume":"15","author":"CE Cox","year":"2008","unstructured":"Cox CE, Cox JM, Ramos D, Meade TL. Intramammary sentinel lymph nodes: what is the clinical significance? Ann Surg Oncol. 2008;15(5):1273\u20134. https:\/\/doi.org\/10.1245\/s10434-007-9769-x.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2219_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0720-048X(01)00373-4","volume":"40","author":"I G\u00fcnhan-Bilgen","year":"2001","unstructured":"G\u00fcnhan-Bilgen I, Memi\u015f A, \u00dcst\u00fcn E. Metastatic intramammary lymph nodes: mammographic and ultrasonographic features. Eur J Radiol. 2001;40(1):24\u20139. https:\/\/doi.org\/10.1016\/S0720-048X(01)00373-4.","journal-title":"Eur J Radiol"},{"issue":"5","key":"2219_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/jcu.20445","volume":"36","author":"BS Edeiken-Monroe","year":"2008","unstructured":"Edeiken-Monroe BS, Monroe DP, Monroe BJ, Arnljot K, Giaccomazza M, Sneige N, et al. Metastases to intramammary lymph nodes in patients with breast cancer: sonographic findings. J Clin Ultrasound. 2008;36(5):279\u201385. https:\/\/doi.org\/10.1002\/jcu.20445.","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"2219_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjsurg.2011.01.030","volume":"203","author":"R Diaz","year":"2012","unstructured":"Diaz R, Degnim AC, Boughey JC, Nassar A, Jakub JW. A positive intramammary lymph node does not mandate a complete axillary node dissection. Am J Surg. 2012;203(2):151\u20135. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.01.030.","journal-title":"Am J Surg"},{"issue":"1","key":"2219_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/ejso.2002.1336","volume":"29","author":"I Tytler","year":"2003","unstructured":"Tytler I, Hayes A, Kissin M. Intramammary sentinel nodes in early breast cancer: can we find them and do they matter? Eur J Surg Oncol (EJSO). 2003;29(1):6\u20138. https:\/\/doi.org\/10.1053\/ejso.2002.1336.","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"5","key":"2219_CR11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1245\/s10434-007-9720-1","volume":"15","author":"M Intra","year":"2008","unstructured":"Intra M, Garcia-Etienne CA, Renne G, Trifiro G, Rotmensz N, Gentilini OD, et al. When sentinel lymph node is intramammary. Ann Surg Oncol. 2008;15(5):1304\u20138. https:\/\/doi.org\/10.1245\/s10434-007-9720-1.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2219_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000340016","volume":"84","author":"SK Lee","year":"2013","unstructured":"Lee SK, Kim S, Choi MY, Kim J, Lee J, Jung SP, et al. The clinical meaning of intramammary lymph nodes. Oncology. 2013;84(1):1\u20135. https:\/\/doi.org\/10.1159\/000340016.","journal-title":"Oncology"},{"issue":"5","key":"2219_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.surg.2009.01.015","volume":"145","author":"SS Vijan","year":"2009","unstructured":"Vijan SS, Hamilton S, Chen B, Reynolds C, Boughey JC, Degnim AC. Intramammary lymph nodes: patterns of discovery and clinical significance. Surgery. 2009;145(5):495\u20139. https:\/\/doi.org\/10.1016\/j.surg.2009.01.015.","journal-title":"Surgery"},{"issue":"4","key":"2219_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.amjsurg.2006.05.011","volume":"192","author":"AA Guth","year":"2006","unstructured":"Guth AA, Mercado C, Roses DF, Hiotis K, Skinner K, Diflo T, et al. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node? Am J Surg. 2006;192(4):502\u20135. https:\/\/doi.org\/10.1016\/j.amjsurg.2006.05.011.","journal-title":"Am J Surg"},{"issue":"1","key":"2219_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.suronc.2008.12.009","volume":"19","author":"BV Hogan","year":"2010","unstructured":"Hogan BV, Peter MB, Shenoy H, Horgan K, Shaaban A. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients. Surg Oncol. 2010;19(1):11\u20136. https:\/\/doi.org\/10.1016\/j.suronc.2008.12.009.","journal-title":"Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02219-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:42:07Z","timestamp":1618303327000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02219-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-67131\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed after the approval of the ethical committee of the National Cancer Institute of Cairo University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}